Abstract
The purpose of this chapter is to describe the experience of Boston Type 1 Keratoprosthesis in Aniridia. Aniridia-associated keratopathy (AAK) affects up to 90 % of aniridic patients and may significantly decrease best-corrected acuity. Poor outcomes of penetrating keratoplasty in aniridia have been reported for over 20 years. Limbal stem cell transplantation can help restore a healthy ocular surface, but requires long term systemic immunosuppression. Boston type 1 Keratoprosthesis implantation represents a promising alternative for visual rehabilitation in AAK patients. The central PMMA optic is unaffected by corneal graft vascularization or conjunctivalization, and may be customized for aphakia or pseudophakia. Multiple studies have reported improved visual outcomes after Kpro implantation with device retention rates of 70 % or greater. Complications include retroprosthetic membranes, corneal melt, device extrusion, and glaucoma.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lee H, Khan R, O’Keefe M (2008) Aniridia: current pathology and management. Acta Ophthalmol 86:708–715
Ramaesh K, Ramaesh T, Dutton GN, Dhillon B (2005) Evolving concepts on the pathogenic mechanisms of aniridia related keratopathy. Int J Biochem Cell Biol 37:547–557
Gomes J, Eagle R, Gomes A, Rapuano C, Cohen E, Laibson P (1996) Recurrent keratopathy after penetrating keratoplasty for aniridia. Cornea 15:457–462
Holland E, Djalilian A, Schwartz G (2003) Management of aniridic keratopathy with keratolimbal allograft: a limbal stem cell transplantation technique. Ophthalmology 110:125–130
Edén U, Fagerholm P, Danyali R, Lagali N (2012) Pathologic epithelial and anterior corneal nerve morphology in early-stage congenital aniridic keratopathy. Ophthalmology 119:1803–1810
Lopez-Garcia J, Garcia-Lozano I, Rivas L, Martinez-Garchitorena J (2006) Congenital aniridia keratopathy treatment. Arch Soc Esp Oftalmol 81:435–444
Kremer I, Rajpal RK, Rapuano CJ, Cohen EJ, Laibson PR (1993) Results of penetrating keratoplaty in aniridia. Am J Ophthalmol 115:317–320
Tiller AM, Odenthal MT, Verbraak FD, Gortzak-Moorstein N (2003) The influence of keratoplasty on visual prognosis in aniridia: a historical review of one large family. Cornea 22:105–110
Hou JH, de la Cruz J, Djalilian AR (2012) Outcomes of Boston keratoprosthesis implantation for failed keratoplasty after keratolimbal allograft. Cornea 31(12):1432–1435
Solomon A, Ellies P, Anderson DF, Touhami A, Grueterich M, Espana EM, Ti SE, Goto E, Feuer WJ, Tseng SC (2002) Long-term outcome of keratolimbal allograft with or without penetrating keratoplasty for total limbal stem cell deficiency. Ophthalmology 109:1159–1166
Tseng S, Prabhasawat P, Barton K, Gray T, Meller D (1998) Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol 16(4):431–441
Shimazaki J, Maruyama F, Shimmura S, Fujishima H, Tsubota K (2001) Immunologic rejection of the central graft after limbal allograft transplantation combined with penetrating keratoplasty. Cornea 20:149–152
Ilari L, Daya SM (2002) Long-term outcomes of keratolimbal allograft for the treatment of severe ocular surface disorders. Ophthalmology 109:1278–1284
Dohlman CH, Harissi-Dagher M, Khan BF, Sippel K, Aquavella JV, Graney JM (2006) Introduction to the use of the Boston keratoprosthesis. Expert Rev Ophthalmol 1:41–48
Akpek EK, Harissi-Dagher M, Petrarca R, Butrus SI, Pineda R, Aquavella JV, Dohlman CH (2007) Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study. Am J Ophthalmol 144(2):227–231
Rixen JJ, Cohen AW, Kitzmann AS, Wagoner MD, Goins KM (2013) Treatment of aniridia with Boston type I keratoprosthesis. Cornea 32(7):947–950
Hassanaly SI, Talajic JC, Harissi-Dagher M (2014) Outcomes following Boston type 1 keratoprosthesis implantation in aniridia patients at the University of Montreal. Am J Ophthalmol 158(2):270–276
Greiner MA, Li JY, Mannis MJ (2011) Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis. Ophthalmology 118(8):1543–1550
Kang JJ, de la Cruz J, Cortina MS (2012) Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure. Cornea 31(12):1436–1440
Patel AP, Wu EI, Ritterband DC, Seedor JA (2012) Boston type 1 keratoprosthesis: the New York eye and ear experience. Eye 26(3):418–425
Robert MC, Harissi-Dagher M (2011) Boston type 1 keratoprosthesis: the CHUM experience. Can J Ophthalmol 46(2):164–168
Srikumaran D, Munoz B, Aldave AJ, Aquavella JV, Hannush SB, Schultze R, Belin M, Akpek EK (2014) Long-term outcomes of Boston type 1 keratoprosthesis implantation: a retrospective multicenter cohort. Ophthalmology. doi:10.1016/j.ophtha.2014.05.030
Sivaraman KR, Hou JH, Allemann N, de la Cruz J, Cortina MS (2013) Retroprosthetic membrane and risk of sterile keratolysis in patients with type I Boston keratoprosthesis. Am J Ophthalmol 155(5):814–822
Sonsino J, Ewald MD (2010) Corrective options for irregular corneas. CL Spectr 180:26
Sayegh RR, Avena Diaz L, Vargas-MartÃn F, Webb RH, Dohlman CH, Peli E (2010) Optical functional properties of the Boston keratoprosthesis. Invest Ophthalmol Vis Sci 51(2):857–863
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Williamson, S., Hsu, K., de la Cruz, J. (2015). Boston Kpro Type I as a Viable Alternative to Visual Rehabilitation in Aniridia Patients: Advances and Limitations. In: Parekh, M., Poli, B., Ferrari, S., Teofili, C., Ponzin, D. (eds) Aniridia. Springer, Cham. https://doi.org/10.1007/978-3-319-19779-1_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-19779-1_9
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-19778-4
Online ISBN: 978-3-319-19779-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)